Center for Scientific Review; Notice of Closed Meetings, 21641 [2010-9652]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 79 / Monday, April 26, 2010 / Notices
Name of Committee: National Center on
Minority Health and Health Disparities.
Date: May 10–12, 2010.
Time: 6 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications and or proposals.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Prabha L. Atreya, PhD,
Chief, Office of Scientific Review, National
Center on Minority Health and Health
Disparities, 6707 Democracy Boulevard,
Suite 800, Bethesda, MD 20892, (301) 594–
8696, atreyapr@mail.nih.gov.
Dated: April 20, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–9638 Filed 4–23–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
sroberts on DSKD5P82C1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; OBT IRG
Member Conflict.
Date: May 17, 2010.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Angela Y. Ng, MBA, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6200,
MSC 7804 (For courier delivery, use MD
20817), Bethesda, MD 20892, 301–435–1715,
nga@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Healthcare
Delivery and Methodologies Competitive
Supplements.
Date: May 18, 2010.
Time: 11:30 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Nov<24>2008
16:56 Apr 23, 2010
Jkt 220001
Place: Sheraton Sand Key Hotel, 1160 Gulf
Boulevard, Clearwater Beach, FL 33767.
Contact Person: Jacinta Bronte-Tinkew,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3164,
MSC 7770, Bethesda, MD 20892, (301) 435–
1503, brontetinkewjm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Genetics and Epidemiology.
Date: May 19, 2010.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Tata Communications, 2355 Dulles
Corner Boulevard, 7th Floor, Herndon, VA
20171 (Virtual Meeting).
Contact Person: Fungai Chanetsa, MPH,
PhD., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3135,
MSC 7770, Bethesda, MD 20892, 301–408–
9436, fungai.chanetsa@nih.hhs.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 20, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–9652 Filed 4–23–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–N–0204]
Infusion Pumps; Public Meeting;
Request for Comments
AGENCY:
Food and Drug Administration,
HHS.
ACTION: Notice of public meeting;
request for comments.
SUMMARY: The Food and Drug
Administration (FDA) is announcing a
public meeting regarding external
infusion pumps. The purpose of the
meeting is to inform the public about
current problems associated with
external infusion pump use, to help the
agency identify quality assurance
strategies to mitigate these problems,
and to solicit comments and input
regarding how to bring more effective
external infusion pumps to market.
Elsewhere in this issue of the Federal
Register, FDA is announcing the
availability of a draft guidnace
document entitled ‘‘Total Product Life
Cycle: Infusion Pump—Premarket
Notification (510(k)) Submissions.’’
Date and Time: The public meeting
will be held on May 25 and 26, 2010,
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
21641
from 8 a.m. to 5 p.m. Persons interested
in attending the meeting must register
by 5 p.m. on May 18, 2010.
Location: The public meeting will be
held at the Hilton Silver Spring hotel,
8727 Colesville Rd., Silver Spring, MD
20910. Seating is limited and available
only on a first-come, first-served basis.
Contact Person: Victoria Wagman,
Food and Drug Administration, Center
for Devices and Radiological Health
(CDRH), 10903 New Hampshire Ave.,
Bldg. 66, rm. 5449, Silver Spring, MD
20993–0002, 301–796–6851, e-mail:
victoria.wagman@fda.hhs.gov.
Registration: Register online for
webinar or onsite attendance at https://
www.fda.gov/MedicalDevices/
NewsEvents/WorkshopsConferences/
ucm203299.htm (select the appropriate
meeting from the list). Please provide
complete contact information for each
attendee, including name, title,
affiliation, address, e-mail, and
telephone number. Registration requests
should be received by May 18, 2010. For
those without Internet access, please
call 301–796–6861 to register.
Registration is free and will be on a firstcome, first-served basis. Early
registration is recommended because
seating is limited and therefore FDA
may limit the number of participants
from each organization. If time and
space permits, onsite registration on the
day of the public meeting will be
provided beginning at 7 a.m. Persons
needing a sign language interpreter or
other special accommodations should
notify Victoria Wagman (see Contact
Person) at least 7 days in advance.
Additional information is also available
at https://www.fda.gov/MedicalDevices/
NewsEvents/WorkshopsConferences/
ucm181140.htm.
Comments: Regardless of attendance
at the public meeting, interested persons
may submit written or electronic
comments. Submit written comments to
the Division of Dockets Management
(HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Submit
electronic comments to https://
www.regulations.gov. Submit a single
copy of electronic comments or two
paper copies of any mailed comments,
except that individuals may submit one
paper copy. Comments are to be
identified with the docket number
found in brackets in the heading of this
document. Please also indicate the
specific question(s) addressed. (See
section II of this document.) Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\26APN1.SGM
26APN1
]]>Agencies
[Federal Register Volume 75, Number 79 (Monday, April 26, 2010)]
[Notices]
[Page 21641]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-9652]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; OBT IRG Member Conflict.
Date: May 17, 2010.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Angela Y. Ng, MBA, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6200, MSC 7804 (For courier
delivery, use MD 20817), Bethesda, MD 20892, 301-435-1715,
nga@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Healthcare Delivery and Methodologies Competitive
Supplements.
Date: May 18, 2010.
Time: 11:30 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton Sand Key Hotel, 1160 Gulf Boulevard, Clearwater
Beach, FL 33767.
Contact Person: Jacinta Bronte-Tinkew, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3164, MSC 7770, Bethesda, MD
20892, (301) 435-1503, brontetinkewjm@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Cancer Genetics and Epidemiology.
Date: May 19, 2010.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Tata Communications, 2355 Dulles Corner Boulevard, 7th
Floor, Herndon, VA 20171 (Virtual Meeting).
Contact Person: Fungai Chanetsa, MPH, PhD., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3135, MSC 7770, Bethesda, MD
20892, 301-408-9436, fungai.chanetsa@nih.hhs.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: April 20, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-9652 Filed 4-23-10; 8:45 am]
BILLING CODE 4140-01-P
